TEL-AVIV, Israel, June 18, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs for the treatment of inflammatory and gastrointestinal diseases and related conditions, including cancer, today announced that Adi Frish, RedHill’s Senior VP Business Development and Licensing, will be presenting at the BIO International Convention, on Thursday, June 26, 2014, at 10:45 a.m. PDT. The conference will be held at the San Diego Convention Center in San Diego, California.
Help employers find you! Check out all the jobs and post your resume.
